InnoCare Announces Acceptance of Supplemental New Drug Application for Orelabrutinib in Relapsed or Refractory Marginal Zone Lymphoma in China

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and…

Eurofins Strengthens Its Comprehensive Food Testing Offering in Japan Through the Acquisition of QSAI Analysis and Research Center Co.,Ltd.

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), the global leader in food testing and a…

Disclosure of data on effects of Agaricus blazei mushroom, KA21 strain for improvement of hair loss & gray hair in human clinical trials and promotion of hair growth in mice, Toei Shinyaku

TOKYO--(BUSINESS WIRE)--On its website www.toeishinyaku.jp, Toei Shinyaku has disclosed data from human clinical trials concerning…

Toei Shinyaku Acquires Patent for Measurement Method of Beta-glucan, a Main Ingredient of Agaricus blazei mushroom

TOKYO--(BUSINESS WIRE)--Through its research on Agaricus blazei, KA21 strain, Toei Shinyaku has established a measurement…

Announcement of Agaricus blazei mushroom, KA21 strain’s Ability to Improve QOL of Athletes at Annual Meeting, Toei Shinyaku

Athlete performance, overall condition, quality of sleep, sense of fatigue, mental condition, concentration ability, muscle…

Jaguar TCS Racing Team Forges Ahead to Seoul for the 2022 Formula E World Championship E-Prix Races

Tata Consultancy Services Partner with Jaguar to Amplify the Importance of Electrification through Famous E-Prix…

ENHERTU® Approved in the U.S. as the First HER2 Directed Therapy for Patients with Previously Treated HER2 Mutant Metastatic Non-Small Cell Lung Cancer

Based on DESTINY-Lung02 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU reported a confirmed objective…